Zhengda Fenghai "Ida la feng sodium chloride injection" approved through consistency evaluation

Yida la sodium chloride injection is a clinically effective brain nerve protector, can reduce cell damage, protect tissue function, clinical lying is mainly used to improve the acute cerebral infarction caused by neurological symptoms, daily life activity ability and dysfunctionThe main applicable departments for the inner, outer, emergency departmentsIda la was recommended by the "China's acute ischemic stroke diagnosis and treatment guide", "China's cerebral hemorrhage diagnosis and treatment guide" and other authoritative guidelines recommended, can effectively improve acute cerebral infarction, cerebral hemorrhage and other patients with nerve function injurydata show that in 2018 China's public medical institutions IndalaFeng injection terminal market size of more than 5 billion yuan, with the product in the domestic ALS clinical indications declaration progress, the product in the specialized treatment of drug indications will be further expanded, broad prospects, great potentialthis approved Yida lafeng sodium chloride injection (100ml) has a glass bottle and three layers of co-squeezed infusion bag two packaging, compared with small volume injection, the product in the storage process is not easy to produce impurities Yidala fydd, at the same time it does not increase the amount of antioxidants, good stability, high safetyIn addition, there is no need to dilute the configuration, can be directly infusion, to avoid secondary pollution, for clinical convenience.